Penumbra Price to Book Ratio 2014-2025 | PEN
Historical price to book ratio values for Penumbra (PEN) over the last 10 years. The current price to book ratio for Penumbra as of February 13, 2026 is 9.76.
| Penumbra Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-02-13 | 339.30 | 9.78 | |
| 2025-09-30 | 253.32 | $34.70 | 7.30 |
| 2025-06-30 | 256.63 | $33.20 | 7.73 |
| 2025-03-31 | 267.41 | $31.35 | 8.53 |
| 2024-12-31 | 237.48 | $29.90 | 7.94 |
| 2024-09-30 | 194.31 | $28.79 | 6.75 |
| 2024-06-30 | 179.97 | $29.90 | 6.02 |
| 2024-03-31 | 223.18 | $31.05 | 7.19 |
| 2023-12-31 | 251.54 | $30.48 | 8.25 |
| 2023-09-30 | 241.91 | $28.63 | 8.45 |
| 2023-06-30 | 344.06 | $27.77 | 12.39 |
| 2023-03-31 | 278.69 | $26.79 | 10.40 |
| 2022-12-31 | 222.46 | $26.21 | 8.49 |
| 2022-09-30 | 189.60 | $25.65 | 7.39 |
| 2022-06-30 | 124.52 | $25.60 | 4.86 |
| 2022-03-31 | 222.13 | $25.47 | 8.72 |
| 2021-12-31 | 287.32 | $25.39 | 11.32 |
| 2021-09-30 | 266.50 | $18.33 | 14.54 |
| 2021-06-30 | 274.06 | $18.41 | 14.89 |
| 2021-03-31 | 270.58 | $17.83 | 15.18 |
| 2020-12-31 | 175.00 | $17.51 | 9.99 |
| 2020-09-30 | 194.38 | $17.07 | 11.39 |
| 2020-06-30 | 178.82 | $17.29 | 10.34 |
| 2020-03-31 | 161.33 | $13.92 | 11.59 |
| 2019-12-31 | 164.27 | $13.87 | 11.84 |
| 2019-09-30 | 134.49 | $13.38 | 10.06 |
| 2019-06-30 | 160.00 | $13.06 | 12.25 |
| 2019-03-31 | 147.01 | $12.63 | 11.64 |
| 2018-12-31 | 122.20 | $12.27 | 9.96 |
| 2018-09-30 | 149.70 | $11.86 | 12.62 |
| 2018-06-30 | 138.15 | $12.37 | 11.17 |
| 2018-03-31 | 115.65 | $12.11 | 9.55 |
| 2017-12-31 | 94.10 | $11.89 | 7.92 |
| 2017-09-30 | 90.30 | $11.31 | 7.98 |
| 2017-06-30 | 87.75 | $11.04 | 7.95 |
| 2017-03-31 | 83.45 | $11.11 | 7.51 |
| 2016-12-31 | 63.80 | $8.57 | 7.45 |
| 2016-09-30 | 75.99 | $8.02 | 9.47 |
| 2016-06-30 | 59.50 | $7.97 | 7.46 |
| 2016-03-31 | 46.00 | $7.75 | 5.93 |
| 2015-12-31 | 53.81 | $7.78 | 6.92 |
| 2015-09-30 | 40.10 | $7.65 | 5.24 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $13.265B | $1.195B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $191.543B | 22.29 |
| Intuitive Surgical (ISRG) | United States | $169.965B | 65.56 |
| IDEXX Laboratories (IDXX) | United States | $49.284B | 47.22 |
| Edwards Lifesciences (EW) | United States | $44.358B | 29.86 |
| Alcon (ALC) | Switzerland | $38.852B | 26.18 |
| IQVIA Holdings (IQV) | United States | $28.755B | 15.53 |
| Mettler-Toledo (MTD) | United States | $27.600B | 31.74 |
| DexCom (DXCM) | United States | $25.382B | 31.14 |
| STERIS (STE) | Ireland | $23.952B | 24.23 |
| Waters (WAT) | United States | $19.045B | 24.36 |
| Coloplast (CLPBY) | Denmark | $17.466B | 26.72 |
| Hologic (HOLX) | United States | $16.723B | 17.50 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.525B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.179B | 11.76 |
| Globus Medical (GMED) | United States | $11.673B | 24.50 |
| SARTORIUS (SSSGY) | Germany | $7.976B | 46.32 |
| Masimo (MASI) | United States | $7.142B | 22.89 |
| Glaukos (GKOS) | United States | $6.131B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $5.930B | 19.62 |
| Teleflex (TFX) | United States | $4.620B | 7.36 |
| TransMedics (TMDX) | United States | $4.392B | 52.03 |
| LivaNova (LIVN) | United Kingdom | $3.490B | 18.85 |
| Integer Holdings (ITGR) | United States | $2.991B | 14.04 |
| Veracyte (VCYT) | United States | $2.779B | 31.67 |
| Elekta AB (EKTAY) | Sweden | $2.267B | 21.21 |
| Nihon Kohden (NHNKY) | Japan | $1.968B | 21.72 |
| Alphatec Holdings (ATEC) | United States | $1.946B | 0.00 |
| Artivion (AORT) | United States | $1.926B | 64.52 |
| UFP Technologies (UFPT) | United States | $1.907B | 25.18 |
| Pulse Biosciences (PLSE) | United States | $1.586B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.570B | 0.00 |
| AxoGen (AXGN) | United States | $1.504B | 0.00 |
| IRadimed (IRMD) | United States | $1.270B | 57.05 |
| Tandem Diabetes Care (TNDM) | United States | $1.267B | 0.00 |
| OPKO Health (OPK) | United States | $0.929B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.842B | 4.56 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.685B | 13.67 |
| SiBone (SIBN) | United States | $0.650B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.613B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.597B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.591B | 34.36 |
| Pacific Biosciences Of California (PACB) | United States | $0.556B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.525B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.489B | 12.74 |
| NeuroPace (NPCE) | United States | $0.483B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.455B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.419B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.371B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.322B | 53.65 |
| RxSight (RXST) | United States | $0.321B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Sight Sciences (SGHT) | United States | $0.285B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.282B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.234B | 0.00 |
| 908 Devices (MASS) | United States | $0.232B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.178B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.169B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.168B | 0.00 |
| Inogen (INGN) | United States | $0.157B | 0.00 |
| CVRx (CVRX) | United States | $0.149B | 0.00 |
| LENSAR (LNSR) | United States | $0.147B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.140B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.140B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.131B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.121B | 0.00 |
| Neuronetics (STIM) | United States | $0.108B | 0.00 |
| Hyperfine (HYPR) | United States | $0.106B | 0.00 |
| Solana (HSDT) | United States | $0.080B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.076B | 0.00 |
| DarioHealth (DRIO) | United States | $0.076B | 0.00 |
| InspireMD (NSPR) | United States | $0.072B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.066B | 0.00 |
| Positron (POSC) | United States | $0.065B | 0.00 |
| Accuray (ARAY) | United States | $0.061B | 0.00 |
| Spectral AI (MDAI) | United States | $0.046B | 0.00 |
| Precision Optics (POCI) | United States | $0.039B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.034B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.024B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.021B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
| Envoy Medical (COCH) | United States | $0.015B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.013B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.012B | 0.00 |
| NexGel (NXGL) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |